MnO2-Mediated cGAS-STING Signaling and Photothermal Effect Amplify Chemodynamic Therapy Induced by Fe-Based Nanoparticle in Tumor Therapy DOI

Xueao Li,

Guodong Cheng, Na Chen

et al.

ACS Applied Nano Materials, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 30, 2025

Language: Английский

Metformin-based nanomedicines for reprogramming tumor immune microenvironment DOI
Jieyu Liu, Xiaoling Li, Yinggang Li

et al.

Theranostics, Journal Year: 2024, Volume and Issue: 15(3), P. 993 - 1016

Published: Dec. 2, 2024

Immunotherapy has transformed current cancer management, and it achieved significant progress over last decades. However, an immunosuppressive tumor microenvironment (TME) diminishes the effectiveness of immunotherapy by suppressing activity immune cells facilitating immune-evasion. Adenosine monophosphate-activated protein kinase (AMPK), a key modulator cellular energy metabolism homeostasis, gained growing attention in anti-tumor immunity. Metformin is usually considered as cornerstone diabetes its role activating AMPK pathway also been extensively explored therapy although findings on remain inconsistent. nanomedicine formulation found to hold potential reprogramming TME through immunometabolic modulation both cells. This review elaborates foundation via metformin-based nanomedicines, offering valuable insights for next generation therapy.

Language: Английский

Citations

34

Nanoparticle innovations in targeted cancer therapy: advancements in antibody–drug conjugates DOI Creative Commons
Magdi T. Abdelhamid, Al-Hassan Soliman Wadan,

Hosam A. Saad

et al.

Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 18, 2025

Language: Английский

Citations

4

Emerging Nanoparticle-Based Diagnostics and Therapeutics for Cancer: Innovations and Challenges DOI Creative Commons

Rachitha Puttasiddaiah,

Nagaraj Basavegowda,

Nityashree Kyathegowdanadoddi Lakshmanagowda

et al.

Pharmaceutics, Journal Year: 2025, Volume and Issue: 17(1), P. 70 - 70

Published: Jan. 7, 2025

Malignant growth is expected to surpass other significant causes of death as one the top reasons for dismalness and mortality worldwide. According a World Health Organization (WHO) study, this illness approximately between 9 10 million instances deaths annually. Chemotherapy, radiation, surgery are three main methods treating cancer. These seek completely eradicate all cancer cells while having fewest possible unintended impacts on healthy cell types. Owing lack target selectivity, majority medications have substantial side effects. On hand, nanomaterials transformed identification, diagnosis, management Nanostructures with biomimetic properties been grown late, fully intent observing sickness. nanostructures be consumed by in areas profound disease. Furthermore, because their extraordinary physicochemical properties, which incorporate nanoscale aspects, more prominent surface region, explicit geometrical features, ability embody different substances within or outside surfaces, remarkable nano-vehicles conveying restorative specialists designated regions. This review discusses recent developments nanostructured materials such graphene, dendrimers, cell-penetrating peptide nanoparticles, nanoliposomes, lipid magnetic nano-omics diagnosis

Language: Английский

Citations

2

Biodegradable and Stimuli-Responsive Nanomaterials for Targeted Drug Delivery in Autoimmune Diseases DOI Creative Commons
Nargish Parvin, Sang Woo Joo, Tapas Kumar Mandal

et al.

Journal of Functional Biomaterials, Journal Year: 2025, Volume and Issue: 16(1), P. 24 - 24

Published: Jan. 14, 2025

Autoimmune diseases present complex therapeutic challenges due to their chronic nature, systemic impact, and requirement for precise immunomodulation avoid adverse side effects. Recent advancements in biodegradable stimuli-responsive nanomaterials have opened new avenues targeted drug delivery systems capable of addressing these challenges. This review provides a comprehensive analysis state-of-the-art nanocarriers such as polymeric nanoparticles, liposomes, hydrogels engineered autoimmune therapies. These are designed degrade safely the body while releasing agents response specific stimuli, including pH, temperature, redox conditions, enzymatic activity. By achieving localized controlled release anti-inflammatory immunosuppressive agents, minimize toxicity enhance efficacy. We discuss underlying mechanisms nanomaterials, recent applications treating rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, design considerations essential clinical translation. Additionally, we address current challenges, biocompatibility, scalability, regulatory hurdles, well future directions integrating advanced nanotechnology with personalized medicine treatment. highlights transformative potential presenting them promising strategy advance precision improve patient outcomes disease management.

Language: Английский

Citations

2

Artificial intelligence for personalized nanomedicine; from material selection to patient outcomes DOI
Hirak Mazumdar, Kamil Reza Khondakar, Suparna Das

et al.

Expert Opinion on Drug Delivery, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 8, 2024

Applying artificial intelligence (AI) to nanomedicine has greatly increased the production of specially engineered nanoscale materials for tailored medicine, marking a significant advancement in healthcare. With use AI, researchers can search through massive databases and find nano-properties that support range therapeutic objectives, eventually producing safer, customized nanomaterials. AI analyzes patient data, including clinical genetic information, predict results individualized care makes recommendations therapy improvement. Furthermore, logically creates nanocarriers give precise controlled drug release patterns optimize advantages minimize undesirable side effects. Even though lot potential nanomedicine, there are still issues data integration techniques, moral dilemmas, requirement governmental backing. Future developments tools multidisciplinary cooperation between scientists with expertise biological sciences nanoengineering essential nanomedicine. Together, these disciplines propel advancements precision contributing ultimate objective—a future which combine provide really The authors this editorial encourage call on scientists, physicians, legislators acknowledge its transform treatment.

Language: Английский

Citations

12

Nanomaterial-based regulation of redox metabolism for enhancing cancer therapy DOI

Xiaodan Jia,

Yue Wang, Yue Qiao

et al.

Chemical Society Reviews, Journal Year: 2024, Volume and Issue: unknown

Published: Jan. 1, 2024

This review provides a comprehensive summary of the dysregulation redox metabolism in cancer cells and advantages latest advances nanomaterial-assisted metabolic regulation therapy.

Language: Английский

Citations

9

Mapping the intellectual structure and emerging trends on nanomaterials in colorectal cancer: a bibliometric analysis from 2003 to 2024 DOI Creative Commons
Man Lu, Yi Liu,

Jin Zhu

et al.

Frontiers in Oncology, Journal Year: 2025, Volume and Issue: 14

Published: Jan. 8, 2025

Colorectal cancer (CRC) is one of thes most prevalent malignant tumors worldwide. Current therapeutic strategies for CRC have limitations, while nanomaterials show significant potential diagnosing and treating CRC. This study utilizes bibliometric analysis to evaluate the current status trends in this field. Research on from 2003 2024 was retrieved Web Science Core Collection (WOSCC). Tools such as CiteSpace, VOSviewer, RStudio, GraphPad Prism, Excel were used analyze hotspots, covering publication trends, countries, institutions, authors, journals, co-citation analysis, keywords. Visual maps created forecast future developments. The includes 3,683 publications by 17,261 authors 3,721 institutions across 100 countries/regions, published 840 journals. Global steadily increased, particularly since 2018. China leads volume citations, with six top ten research seven cited United States excels citation impact academic centrality. Both countries currently dominate field, underscoring urgent need enhanced international collaboration. Ramezani M Abnous K lead H-index, Siegel RL highly cited. International Journal Nanomedicine has highest volume, Controlled Release In addition "colorectal cancer" "nanoparticles," common keyword "drug delivery." Emerging areas "metal-organic frameworks (MOFs)" "green synthesis" are gaining attention leading hotspots. offers an in-depth application CRC, promoting interdisciplinary collaboration advancing scientific progress

Language: Английский

Citations

1

Targeted delivery and controlled release of polymeric nanomedicines for tumor therapy DOI Creative Commons
Na Shen, Weidong Zhao,

Hongyu Chu

et al.

Fundamental Research, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Language: Английский

Citations

1

Smart self-transforming nano-systems for overcoming biological barrier and enhancing tumor treatment efficacy DOI
Jun Tao,

Weiqing Ning,

Wei Lü

et al.

Journal of Controlled Release, Journal Year: 2025, Volume and Issue: 380, P. 85 - 107

Published: Feb. 5, 2025

Language: Английский

Citations

1

Glioma stem cell membrane-camouflaged photothermal nanozyme for synergistic antitumor via dual-targeted drug delivery across blood-brain barrier DOI Creative Commons
Jialiang Lin,

Zuoming Sun,

Yue Huang

et al.

Chemical Engineering Journal, Journal Year: 2025, Volume and Issue: unknown, P. 160181 - 160181

Published: Feb. 1, 2025

Language: Английский

Citations

1